Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABUS | SLS | DRUG | ||
| Company | Arbutus Biopharma Corp | Sellas Life Sciences Group Inc | Bright Minds Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.14 | 4.75 | 84.19 | ||
| High | 4.38 | 4.84 | 87.00 | ||
| Low | 4.13 | 4.53 | 81.99 | ||
| Latest | 4.37 | 4.76 | 85.18 | ||
| Change | +0.22 | unch | +1.63 | ||
| % Change | +5.30% | unch | +1.95% | ||
| Volume | 1,391,800 | 4,053,800 | 138,000 | ||
| 20-Day Average Volume | 1,960,595 | 7,224,920 | 176,370 | ||
| Previous Close | 4.15 | 4.76 | 83.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.38 | 4.77 | 74.76 | ||
| 20-Day Raw Stochastic | 47.06% | 46.55% | 91.25% | ||
| 20-Day Relative Strength | 49.37 | 51.21 | 58.95 | ||
| Weighted Alpha | +32.29 | +168.56 | +131.73 | ||
| Today's Opinion | 8% Sell | 72% Buy | 56% Buy | ||
| Previous Opinion | 40% Sell | 72% Buy | 56% Buy | ||
| Last Month's Opinion | 32% Buy | 96% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.02% since 04/06/26 | +5.08% since 04/06/26 | +13.60% since 04/06/26 | ||
| Low | 4.13 on 04/13/26 | 4.35 on 04/07/26 | 71.19 on 04/07/26 | ||
| High | 4.60 on 04/08/26 | 5.18 on 04/09/26 | 87.00 on 04/13/26 | ||
| 1-Month | |||||
| %Chg | +2.58% since 03/13/26 | -11.36% since 03/13/26 | +18.31% since 03/13/26 | ||
| Low | 4.13 on 04/13/26 | 3.95 on 03/30/26 | 66.20 on 03/30/26 | ||
| High | 4.64 on 03/25/26 | 5.69 on 03/16/26 | 87.00 on 04/13/26 | ||
| 3-Month | |||||
| %Chg | -7.81% since 01/13/26 | +14.70% since 01/13/26 | -4.73% since 01/13/26 | ||
| Low | 3.50 on 02/02/26 | 3.46 on 02/12/26 | 66.20 on 03/30/26 | ||
| High | 4.86 on 01/14/26 | 6.14 on 03/09/26 | 91.50 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +2.10% since 10/13/25 | +138.00% since 10/13/25 | +31.11% since 10/13/25 | ||
| Low | 3.50 on 02/02/26 | 1.39 on 12/02/25 | 50.00 on 11/05/25 | ||
| High | 5.07 on 12/15/25 | 6.14 on 03/09/26 | 123.75 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 854,239 | 854,815 | 828,988 | ||
| Shares Outstanding, K | 195,478 | 179,583 | 9,732 | ||
| Annual Sales | 14,080,000 | 0 | 0 | ||
| Annual Net Income | -33,500,000 | -26,860,000 | -8,740,000 | ||
| Last Quarter Sales | 1,050,000 | 0 | 0 | ||
| Last Quarter Net Income | -3,760,000 | -7,660,000 | -5,430,000 | ||
| 60-Month Beta | 0.74 | 2.22 | -5.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 03/23/26 | -0.05 on 03/19/26 | -0.70 on 02/12/26 | ||
| Latest Earnings Date | 05/13/26 | 05/12/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||